Self-feeding implants to improve and accelerate tissue healing using nutritional nanoparticles

The NutriBone project aims to develop a patented self-feeding bone implant that enhances long-term viability and reduces failure rates for large bone defects through glycogen-based glucose release.

Subsidie
€ 150.000
2024

Projectdetails

Introduction

Keeping large (>1cm³) living tissues alive is an unresolved key challenge that hinders many clinical and industrial applications, including tissue/organ transplants, engineered tissues, drug screening models, and lab-grown meat. While natural tissues within our body are continuously provided with nutrients via the bloodstream, engineered, explanted, or even implanted tissues have to rely on the slow diffusion of nutrients until perfused vascularization is achieved. This commonly leads to tissue starvation, which inevitably causes tissue failure.

Project Overview

The NutriBone project is based on the logical yet never-before-explored premise that these tissues need to provide their own nutrients if the environment cannot do so. This is an innovative concept named self-feeding.

Key Discoveries

We have surprisingly discovered that glycogen offers cell-driven long-term release of physiologically relevant quantities of glucose, enabling:

  1. Long-term implant survival
  2. Accelerated tissue formation
  3. Reduced inflammation and immune responses
  4. Improved vascularization

As this approach is a first-of-its-kind, we have patented it and here propose its valorization.

Market Focus

We propose to develop a marketable self-feeding bone implant to address the current clinical challenge of critically sized bone defects. Although our technology is relevant for many clinical applications, we will focus on large bone defects.

Importance of Bone Implants

Bone is the second most implanted tissue, but implant failure remains high, leading to high medical costs and low quality of life for patients. Moreover, bone implants represent the largest, and still fast-growing market for engineered tissues, while awaiting a solution to maintain implant viability. Thus, we can foresee a concrete path-to-market.

Development Strategy

To this end, we will perform product development towards a minimum viable product, establishing a roadmap for certification, and conducting market research as well as business plan development to ensure a good product-market fit, including a market entry and exit strategy.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 150.000
Totale projectbegroting€ 150.000

Tijdlijn

Startdatum1-12-2024
Einddatum31-5-2026
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • UNIVERSITEIT TWENTEpenvoerder

Land(en)

Netherlands

Vergelijkbare projecten binnen European Research Council

ERC Consolid...

Engineering nanoparticle-polymer interactions to create instructive, tough nanocomposite hydrogels without negatively impacting self-healing behavior for bone tissue regeneration

Nano4Bone aims to engineer self-healing hydrogels with enhanced mechanical properties and bioactive nanoparticles for effective bone tissue regeneration in osteosarcoma treatment.

€ 2.000.000
ERC Proof of...

A 3D-printable biomimetic bone regeneration material

PRIOBONE aims to validate a novel 3D-printable, bone-mimetic material for critical-size bone defects, offering a customizable, cost-effective solution to improve healing outcomes.

€ 150.000
ERC Proof of...

Bioactive reinforcing bioink for hybrid bioprinting of implantable bone

The project aims to develop 'BioForceInk,' a bioactive bioink for hybrid 3D bioprinting of vascularized bone implants, enhancing mechanical strength and biological functionality for clinical applications.

€ 150.000
ERC Starting...

Biodegradable MEMS implants for nerve repair

Develop biodegradable MEMS implants for nerve repair using innovative mechanical stimulation strategies to enhance neural regeneration post-injury.

€ 1.672.968
ERC Proof of...

Novel bio-inspired energy harvesting and storage all-in-one platform for implantable devices based on peptide nanotechnology

Developing PepZoPower, a biocompatible energy harvesting and storage device using piezoelectric peptides, to create autonomous, miniaturized power sources for implantable biomedical systems.

€ 150.000

Vergelijkbare projecten uit andere regelingen

EIC Accelerator

The Holy Grail in Bone regeneration

GreenBone aims to revolutionize bone grafts with a synthetic Rattan wood-based implant that mimics natural bone, enhancing regeneration and targeting the spinal market by 2025.

€ 2.458.128
EIC Pathfinder

Smart 4D biodegradable metallic shape-shifting implants for dynamic tissue restoration

BIOMET4D aims to revolutionize reconstructive surgery with shape-morphing implants for dynamic tissue restoration, enhancing regeneration while reducing costs and invasiveness.

€ 4.039.541
EIC Pathfinder

Blood as energy source to power smart cardiac devices

The BLOOD2POWER project aims to develop energy-harvesting vascular grafts using triboelectric nanogenerators to monitor performance and prevent failure through wireless data transmission.

€ 2.885.525
Mkb-innovati...

Ceramic paste for 3D-printable bone implants

Z3DLABS en Delft Solids Solutions ontwikkelen een 3D printbare keramische pasta voor patiëntspecifieke, bio-compatibele botimplantaten met een langere levensduur en lagere behandelkosten.

€ 195.510
Mkb-innovati...

Ontwikkelen nieuw middel voor de lokale genezing van botbreuken

Dit project ontwikkelt een nieuwe formulering van microspheres met groeifactoren voor Demineralized Bone Material (DBM) om de effectiviteit bij moeilijk genezende botbreuken te verbeteren.

€ 194.500